KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Moderna (MRNA) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Moderna (MRNA) over the last 7 years, with Q4 2022 value amounting to $385.0 million.

  • Moderna's Shares Outstanding fell 446.65% to $385.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $385.0 million, marking a year-over-year decrease of 446.65%. This contributed to the annual value of $385.0 million for FY2022, which is 446.65% down from last year.
  • As of Q4 2022, Moderna's Shares Outstanding stood at $385.0 million, which was down 446.65% from $392.0 million recorded in Q2 2022.
  • Over the past 5 years, Moderna's Shares Outstanding peaked at $509.4 million during Q2 2018, and registered a low of $328.9 million during Q1 2019.
  • Its 5-year average for Shares Outstanding is $396.1 million, with a median of $395.0 million in 2020.
  • Per our database at Business Quant, Moderna's Shares Outstanding soared by 40454.71% in 2018 and then crashed by 3522.01% in 2019.
  • Quarter analysis of 5 years shows Moderna's Shares Outstanding stood at $329.0 million in 2018, then grew by 2.43% to $337.0 million in 2019, then increased by 18.4% to $399.0 million in 2020, then grew by 1.0% to $403.0 million in 2021, then dropped by 4.47% to $385.0 million in 2022.
  • Its last three reported values are $385.0 million in Q4 2022, $392.0 million for Q2 2022, and $400.0 million during Q1 2022.